網絡轉載：、、

據中國產業經濟信息網（中(zhong)(zhong)(zhong)宣部主管(guan)(guan)、人(ren)民日報社代管(guan)(guan)，中(zhong)(zhong)(zhong)國(guo)報業(ye)(ye)協(xie)會(hui)(hui)主辦的(de)(de)(de)(de)中(zhong)(zhong)(zhong)國(guo)產(chan)經及行(xing)業(ye)(ye)信息官方權威發布平臺）等(deng)多(duo)家(jia)媒(mei)體報道(dao)，福(fu)萊明生物原(yuan)研(yan)創新的(de)(de)(de)(de)重組(zu) I 型人(ren)源化(hua)膠原(yuan)蛋白福(fu)活因子（英文名FHTFF，研(yan)發代號(hao)FLM-3.x），已于2024年11月8日獲得國(guo)際(ji)化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)成(cheng)(cheng)(cheng)(cheng)(cheng)分(fen)(fen)(fen)(fen)命(ming)(ming)名委員會(hui)(hui)(International Cosmetic Ingredient Nomenclature Committee (INC)審定和分(fen)(fen)(fen)(fen)配(pei)的(de)(de)(de)(de)國(guo)際(ji)化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)原(yuan)料標(biao)準(zhun)(zhun)名稱(cheng)(cheng)(cheng)(cheng)sh-Polypeptide-47， Mono ID為25261 。INCI名稱(cheng)(cheng)(cheng)(cheng)是國(guo)際(ji)公認的(de)(de)(de)(de)識別(bie)化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)成(cheng)(cheng)(cheng)(cheng)(cheng)分(fen)(fen)(fen)(fen)的(de)(de)(de)(de)統(tong)一(yi)、系統(tong)的(de)(de)(de)(de)名稱(cheng)(cheng)(cheng)(cheng)，許多(duo)國(guo)家(jia)法規規定化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)的(de)(de)(de)(de)成(cheng)(cheng)(cheng)(cheng)(cheng)分(fen)(fen)(fen)(fen)標(biao)簽(qian)使(shi)用INCI名稱(cheng)(cheng)(cheng)(cheng)。國(guo)際(ji)化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)成(cheng)(cheng)(cheng)(cheng)(cheng)分(fen)(fen)(fen)(fen)命(ming)(ming)名委員會(hui)(hui)由(you)來(lai)自行(xing)業(ye)(ye)、學術界(jie)、監(jian)管(guan)(guan)機構和專業(ye)(ye)協(xie)會(hui)(hui)的(de)(de)(de)(de)專家(jia)與科學家(jia)組(zu)成(cheng)(cheng)(cheng)(cheng)(cheng)，INCI清(qing)單是化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)和個人(ren)護理(li)產(chan)品(pin)(pin)(pin)(pin)中(zhong)(zhong)(zhong)使(shi)用的(de)(de)(de)(de)最(zui)全面的(de)(de)(de)(de)成(cheng)(cheng)(cheng)(cheng)(cheng)分(fen)(fen)(fen)(fen)清(qing)單。為規范(fan)國(guo)際(ji)化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)原(yuan)料標(biao)準(zhun)(zhun)中(zhong)(zhong)(zhong)文名稱(cheng)(cheng)(cheng)(cheng)命(ming)(ming)名，《國(guo)際(ji)化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)原(yuan)料標(biao)準(zhun)(zhun)中(zhong)(zhong)(zhong)文名稱(cheng)(cheng)(cheng)(cheng)目錄》是由(you)國(guo)家(jia)管(guan)(guan)理(li)部門(men)對《國(guo)際(ji)化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)原(yuan)料字(zi)典和手冊》中(zhong)(zhong)(zhong)所(suo)收錄的(de)(de)(de)(de)原(yuan)料INCI命(ming)(ming)名進(jin)行(xing)翻譯而來(lai)，以(yi)規范(fan)和統(tong)一(yi)化(hua)妝(zhuang)(zhuang)品(pin)(pin)(pin)(pin)原(yuan)料的(de)(de)(de)(de)中(zhong)(zhong)(zhong)文名稱(cheng)(cheng)(cheng)(cheng)。

福活(huo)因子(zi)FHTFF是福萊(lai)明(ming)生(sheng)物(wu)(wu)聯合華南理工大學和(he)(he)(he)中國(guo)(guo)(guo)科學院，利用(yong)Al設計(ji)，將(jiang)人膠(jiao)原(yuan)(yuan)(yuan)蛋(dan)(dan)白(bai)的(de)保守(shou)區域(yu)重(zhong)組(zu)(zu)后(hou)融合輔助(zhu)肽段，首次在I 型(xing)(xing)膠(jiao)原(yuan)(yuan)(yuan)蛋(dan)(dan)白(bai)序列的(de)基礎(chu)上，創造(zao)性的(de)形成(cheng)(cheng) I 型(xing)(xing)和(he)(he)(he) III 型(xing)(xing)膠(jiao)原(yuan)(yuan)(yuan)蛋(dan)(dan)白(bai)的(de)高級結構(gou)，從而兼(jian)具(ju)了(le) I 型(xing)(xing)細胞骨架支撐作用(yong)和(he)(he)(he) III 型(xing)(xing)彈性柔韌功能的(de)雙重(zhong)特征。依據國(guo)(guo)(guo)家藥(yao)監局(ju)命名指導原(yuan)(yuan)(yuan)則，該(gai)創新融合蛋(dan)(dan)白(bai)屬(shu)于B型(xing)(xing)重(zhong)組(zu)(zu) I 型(xing)(xing)人源(yuan)化(hua)膠(jiao)原(yuan)(yuan)(yuan)蛋(dan)(dan)白(bai)，成(cheng)(cheng)功獲(huo)得國(guo)(guo)(guo)際基因蛋(dan)(dan)白(bai)數據庫收錄。在完成(cheng)(cheng)了(le)中國(guo)(guo)(guo)國(guo)(guo)(guo)家藥(yao)監局(ju)醫療器(qi)(qi)械原(yuan)(yuan)(yuan)料(liao)主(zhu)文(wen)檔登記后(hou)，進一步(bu)實現(xian)了(le)該(gai)創新生(sheng)物(wu)(wu)材料(liao)的(de)合成(cheng)(cheng)生(sheng)物(wu)(wu)學規模化(hua)生(sheng)產(chan)。如今(jin)，福活(huo)因子(zi)FHTFF獲(huo)得國(guo)(guo)(guo)際化(hua)妝(zhuang)品(pin)(pin)原(yuan)(yuan)(yuan)料(liao)標準名稱，成(cheng)(cheng)為(wei)國(guo)(guo)(guo)際化(hua)妝(zhuang)品(pin)(pin)創新原(yuan)(yuan)(yuan)料(liao)目(mu)錄新成(cheng)(cheng)員，意味著福萊(lai)明(ming)生(sheng)物(wu)(wu)原(yuan)(yuan)(yuan)研的(de)重(zhong)組(zu)(zu) I 型(xing)(xing)人源(yuan)化(hua)膠(jiao)原(yuan)(yuan)(yuan)蛋(dan)(dan)白(bai)不僅填補(bu)了(le)國(guo)(guo)(guo)內(nei)市(shi)場空白(bai)，還獲(huo)得了(le)國(guo)(guo)(guo)際認可(ke)，作為(wei)創新生(sheng)物(wu)(wu)原(yuan)(yuan)(yuan)料(liao)具(ju)備了(le)國(guo)(guo)(guo)內(nei)外生(sheng)物(wu)(wu)醫藥(yao)、醫療器(qi)(qi)械和(he)(he)(he)化(hua)妝(zhuang)品(pin)(pin)領域(yu)的(de)多重(zhong)應用(yong)潛能。

福萊(lai)明生(sheng)物已經基于福活因(yin)子FHTFF開發了針對皮(pi)膚(fu)黏膜損傷、干(gan)燥松弛和(he)色素沉著等(deng)問題的外用二類醫(yi)療器(qi)械 I 型膠(jiao)原(yuan)(yuan)敷料、敷貼和(he)護膚(fu)精(jing)華(hua)等(deng)衍(yan)生(sheng)產品(pin)，并(bing)在(zai)同濟大(da)(da)學附屬第(di)十人(ren)民(min)醫(yi)院、上海中(zhong)(zhong)醫(yi)藥大(da)(da)學附屬第(di)七人(ren)民(min)醫(yi)院進行(xing)了多中(zhong)(zhong)心臨床(chuang)試驗，結果證(zheng)實 I 型膠(jiao)原(yuan)(yuan)敷料可以顯著改善黏膜干(gan)燥松弛癥狀，對壓(ya)力性尿(niao)失禁（漏尿(niao)）等(deng)輕度盆底(di)功能障(zhang)礙(ai)癥狀也(ye)有(you)較(jiao)好(hao)的輔助(zhu)治療作用。近期公司將加(jia)大(da)(da)投入，集(ji)中(zhong)(zhong)優勢資(zi)源，開發其在(zai)改善肌膚(fu)膚(fu)質和(he)皮(pi)膚(fu)黏膜填充等(deng)方(fang)面的三(san)類創新醫(yi)療器(qi)械產品(pin)。

原文鏈接

媒體：中國產業經濟信息網
//www.cinic.org.cn/zgzz/qy/1563357.html
媒(mei)體：中華網科技
//tech.china.com/jujiao/2024/1114/1602979.html
媒體：網易新聞-大灣區發展網
//www.163.com/dy/article/JGVASNFM0511PVPC.html